Anthony L. Almada has worked within the dietary supplement industry since 1975. He performed his undergraduate training (B.Sc.) in physiology and nutritional biochemistry at the University of California, Irvine and California State University, Long Beach. He then performed his graduate (M.Sc.) research at the University of California, Berkeley, exploring the impact of exercise upon tissue antioxidant status and kinetics, including vitamins C and E, coenzyme Q and glutathione. While directing R&D at different ingredient and finished product companies he introduced vanadyl sulfate (1989) and the first thermogenic product (1991) to the market. In 1992 Anthony co-founded Experimental and Applied Sciences (EAS), now the largest sports nutrition company on a global scale. During his tenure as Chief Scientific Officer and President he developed a university research program that completed over 15 clinical studies in the first 3 years of the company’s history, also yielding 2 issued patents. After selling EAS he co-founded a medical food company that developed a university clinically-validated product to prevent HIV wasting. He then created IMAGINutrition, Inc., an innovation and science marketing think tank focusing upon nutritional technologies, IP clinical research validation and science-driven media campaigns. He has collaborated on over 50 university clinical trials, ranging from AIDS/HIV and ALS to zinc metabolism in osteoarthritis. Anthony excels in intellectual property creation, novel product development, scientific validation and the transfer of technology into the marketplace.
Anthony L. Almada has worked within the dietary supplement industry since 1975. He performed his undergraduate training (B.Sc.) in physiology and nutritional biochemistry at the University of California, Irvine and California State University, Long Beach. He then performed his graduate (M.Sc.) research at the University of California, Berkeley, exploring the impact of exercise upon tissue antioxidant status and kinetics, including vitamins C and E, coenzyme Q and glutathione. While directing R&D at different ingredient and finished product companies he introduced vanadyl sulfate (1989) and the first thermogenic product (1991) to the market. In 1992 Anthony co-founded Experimental and Applied Sciences (EAS), now the largest sports nutrition company on a global scale. During his tenure as Chief Scientific Officer and President he developed a university research program that completed over 15 clinical studies in the first 3 years of the company’s history, also yielding 2 issued patents. After selling EAS he co-founded a medical food company that developed a university clinically-validated product to prevent HIV wasting. He then created IMAGINutrition, Inc., an innovation and science marketing think tank focusing upon nutritional technologies, IP clinical research validation and science-driven media campaigns. He has collaborated on over 50 university clinical trials, ranging from AIDS/HIV and ALS to zinc metabolism in osteoarthritis. Anthony excels in intellectual property creation, novel product development, scientific validation and the transfer of technology into the marketplace.